These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9453613)

  • 21. Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone.
    Marsollier L; Aubry J; Coutanceau E; André JP; Small PL; Milon G; Legras P; Guadagnini S; Carbonnelle B; Cole ST
    Cell Microbiol; 2005 Jul; 7(7):935-43. PubMed ID: 15953026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F.
    Ranger BS; Mahrous EA; Mosi L; Adusumilli S; Lee RE; Colorni A; Rhodes M; Small PL
    Infect Immun; 2006 Nov; 74(11):6037-45. PubMed ID: 16923788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic cutaneous mycobacterial ulcers due to Mycobacterium ulcerans (Buruli ulcer): the first indigenous case report from Jordan and a literature review.
    Al Ramahi JW; Annab H; Al Karmi M; Kirresh B; Wreikat M; Batarseh R; Yacoub M; Kaderi M
    Int J Infect Dis; 2017 May; 58():77-81. PubMed ID: 28344056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans.
    Snyder DS; Small PL
    Microb Pathog; 2003 Feb; 34(2):91-101. PubMed ID: 12623277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model.
    Liu Y; Gao Y; Liu J; Tan Y; Liu Z; Chhotaray C; Jiang H; Lu Z; Chiwala G; Wang S; Makafe G; Islam MM; Hameed HMA; Cai X; Wang C; Li X; Tan S; Zhang T
    Nat Commun; 2019 Jan; 10(1):524. PubMed ID: 30705268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium ulcerans cytotoxicity in an adipose cell model.
    Dobos KM; Small PL; Deslauriers M; Quinn FD; King CH
    Infect Immun; 2001 Nov; 69(11):7182-6. PubMed ID: 11598099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
    Sarfo FS; Phillips RO; Rangers B; Mahrous EA; Lee RE; Tarelli E; Asiedu KB; Small PL; Wansbrough-Jones MH
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e577. PubMed ID: 20052267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
    Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM
    Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycolactones and Mycobacterium ulcerans disease.
    van der Werf TS; Stinear T; Stienstra Y; van der Graaf WT; Small PL
    Lancet; 2003 Sep; 362(9389):1062-4. PubMed ID: 14522538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium ulcerans infection.
    van der Werf TS; van der Graaf WT; Tappero JW; Asiedu K
    Lancet; 1999 Sep; 354(9183):1013-8. PubMed ID: 10501380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.
    Torrado E; Fraga AG; Castro AG; Stragier P; Meyers WM; Portaels F; Silva MT; Pedrosa J
    Infect Immun; 2007 Feb; 75(2):977-87. PubMed ID: 17145944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 36. Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa.
    Vandelannoote K; Phanzu DM; Kibadi K; Eddyani M; Meehan CJ; Jordaens K; Leirs H; Portaels F; Stinear TP; Harris SR; de Jong BC
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30728280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer.
    Doig KD; Holt KE; Fyfe JA; Lavender CJ; Eddyani M; Portaels F; Yeboah-Manu D; Pluschke G; Seemann T; Stinear TP
    BMC Genomics; 2012 Jun; 13():258. PubMed ID: 22712622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated
    Hammoudi N; Dizoe AS; Regoui S; Davoust B; Drancourt M; Bouam A
    Am J Trop Med Hyg; 2019 Sep; 101(3):491-493. PubMed ID: 31333157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans.
    Röltgen K; Pluschke G
    Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.
    Fraga AG; Cruz A; Martins TG; Torrado E; Saraiva M; Pereira DR; Meyers WM; Portaels F; Silva MT; Castro AG; Pedrosa J
    Infect Immun; 2011 Jan; 79(1):421-30. PubMed ID: 20974825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.